US breast cancer drug decision 'marks start of death panels' - Telegraph

Image by borman818 via FlickrAmerica's health watchdog is considering revoking its approval of the drug Avastin for use on women with advanced breast cancer, leading to accusations that it will mark the start of 'death panel' drug rationing.
A decision to rescind endorsement of the drug would reignite the highly charged debate over US health care reform and how much the state should spend on new and expensive treatments. Full Story>>

Related articles:

• FDA Considers Dropping Avastin Approval, Approves Five-Day Emergency Contraception Pill (medicalnewstoday.com)
• The Avastin Mugging (online.wsj.com)
• Panel doesn't back Avastin for breast cancer (sfgate.com)